Application 761232
- Type
- BLA
- Sponsor
- BEIGENE
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 761232 | Tevimbra | tislelizumab-jsgr | 351(a) | Rx | 2026-10-01 |
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | TEVIMBRA | TISLELIZUMAB-JSGR | INJECTION;SOLUTION | 100MG/10ML | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.